{"key":"melanotan-i","slug":"melanotan-i","name":"Melanotan I","other_names":["MT-1","mt1","Afamelanotide"],"kind":"single","area":{"slug":"longevity","name":"Skin and longevity"},"classification":"Melanocortin-1 receptor agonist (afamelanotide)","standing":{"id":"approved","label":"Licensed medicine","rank":5},"summary":"A linear analogue of alpha-MSH. As afamelanotide it is licensed as an implant for the light sensitivity of erythropoietic protoporphyria.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":124,"in_humans":87,"clinical_trials":13},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/melanotan-i","article":null,"evidence":{"query":"(afamelanotide[tiab] OR \"melanotan I\"[tiab] OR \"melanotan-1\"[tiab])","fetched_at":"2026-11-16T23:01:45.248Z","counts":{"rcts":5,"human":87,"total":124,"reviews":48,"clinicalTrials":13},"years":[{"year":2012,"count":5},{"year":2013,"count":6},{"year":2014,"count":5},{"year":2015,"count":8},{"year":2016,"count":6},{"year":2017,"count":8},{"year":2018,"count":3},{"year":2019,"count":4},{"year":2020,"count":9},{"year":2021,"count":9},{"year":2022,"count":5},{"year":2023,"count":17},{"year":2024,"count":14},{"year":2025,"count":13},{"year":2026,"count":12}],"top":[{"doi":"10.1056/NEJMoa1411481","url":"https://pubmed.ncbi.nlm.nih.gov/26132941/","kind":"rct","pmid":"26132941","year":2015,"title":"Afamelanotide for Erythropoietic Protoporphyria","venue":"The New England journal of medicine","authors":"Langendonk JG, Balwani M, Anderson KE, et al."},{"doi":"10.1111/ced.12203","url":"https://pubmed.ncbi.nlm.nih.gov/24256215/","kind":"trial","pmid":"24256215","year":2014,"title":"Efficacy of the melanocortin analogue Nle4-D-Phe7-α-melanocyte-stimulating hormone in the treatment of patients with Hailey-Hailey disease","venue":"Clinical and experimental dermatology","authors":"Biolcati G, Aurizi C, Barbieri L, et al."},{"doi":"10.1111/j.1468-3083.2012.04658.x","url":"https://pubmed.ncbi.nlm.nih.gov/22845050/","kind":"trial","pmid":"22845050","year":2014,"title":"Beneficial effects of the melanocortin analogue Nle4-D-Phe7-α-MSH in acne vulgaris","venue":"Journal of the European Academy of Dermatology and Venereology : JEADV","authors":"Böhm M, Ehrchen J, Luger TA"},{"doi":"10.1159/000362174","url":"https://pubmed.ncbi.nlm.nih.gov/25402764/","kind":"trial","pmid":"25402764","year":2015,"title":"Evaluation of the immunogenicity of the synthetic α-melanocyte-stimulating hormone (α-MSH) analogue afamelanotide ([Nle4-D-Phe7]-α-MSH, Scenesse®) in erythropoietic protoporphyria patients by ELISA detecting both anti-afamelanotide and anti-α-MSH antibodies","venue":"Skin pharmacology and physiology","authors":"Lengweiler S, Kreim S, Barman-Aksözen J, et al."},{"doi":"10.1111/j.1751-1097.2009.00595.x","url":"https://pubmed.ncbi.nlm.nih.gov/19656325/","kind":"trial","pmid":"19656325","year":2009,"title":"Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone","venue":"Photochemistry and photobiology","authors":"Harms JH, Lautenschlager S, Minder CE, et al."},{"doi":"10.1111/php.70081","url":"https://pubmed.ncbi.nlm.nih.gov/41766687/","kind":"trial","pmid":"41766687","year":2026,"title":"Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study","venue":"Photochemistry and photobiology","authors":"Shetty N, Quiñonez RL, Ceresnie MS, et al."},{"doi":"10.1007/s00105-015-3671-4","url":"https://pubmed.ncbi.nlm.nih.gov/26315100/","kind":"review","pmid":"26315100","year":2015,"title":"[Undesirable pigmentation]","venue":"Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete","authors":"Bayerl C"},{"doi":"10.3390/ijms242417306","url":"https://pubmed.ncbi.nlm.nih.gov/38139134/","kind":"review","pmid":"38139134","year":2023,"title":"Vitiligo: Pathogenesis and New and Emerging Treatments","venue":"International journal of molecular sciences","authors":"Perez-Bootello J, Cova-Martin R, Naharro-Rodriguez J, et al."},{"doi":"10.1016/j.det.2019.08.005","url":"https://pubmed.ncbi.nlm.nih.gov/31753192/","kind":"review","pmid":"31753192","year":2020,"title":"Phototherapy for Vitiligo","venue":"Dermatologic clinics","authors":"Zubair R, Hamzavi IH"},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/38598652/","kind":"review","pmid":"38598652","year":2012,"title":"Afamelanotide","venue":"","authors":""}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}